Related Experiment Video
Updated: Feb 27, 2026
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
Neonatal Meningitis: Overcoming Challenges in Diagnosis, Prognosis, and Treatment with Omics
Scott M Gordon1, Lakshmi Srinivasan1, Mary Catherine Harris2
1Division of Neonatology, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
Insights
Neonatal meningitis remains a severe threat, with high mortality and lifelong complications for survivors. Understanding immune responses is key to improving outcomes for this challenging infant infection.
Area of Science:
- Pediatrics
- Infectious Diseases
- Neuroscience
Background:
- Neonatal meningitis is a severe infection with persistent high mortality rates and significant long-term neurological sequelae in survivors.
- Despite advances in antimicrobial therapy and clinical suspicion, predicting outcomes and preventing severe complications in affected infants remains challenging.
- Current diagnostic methods for infant meningitis are invasive, time-consuming, and technically difficult, delaying critical early treatment.
Purpose of the Study:
- To review the diagnostic, prognostic, and therapeutic challenges associated with neonatal meningitis.
- To explore the underlying mechanisms of brain injury and host immune response in neonatal meningitis.
- To identify promising avenues for future research based on omics data.
Main Methods:
- Review of existing literature on neonatal meningitis.
- Analysis of transcriptomic, proteomic, and metabolomic data.
- Discussion of host immune response and neuronal injury mechanisms.
Main Results:
- Neonatal meningitis leads to significant mortality and lifelong neurodevelopmental deficits in survivors.
- Early diagnosis and treatment are crucial but challenging due to invasive and time-intensive methods.
- Elevated pro- and anti-inflammatory cytokines are observed, but their precise role in brain injury is not fully understood.
Conclusions:
- Improved strategies for diagnosing and predicting outcomes in neonatal meningitis are urgently needed.
- Further investigation into the host immune response, particularly using omics approaches, is essential for understanding and mitigating brain injury.
- Targeted research is required to develop more effective treatments and improve the prognosis for infants with meningitis.
Abstract:
Neonatal meningitis is a devastating condition. Prognosis has not improved in decades, despite the advent of improved antimicrobial therapy and heightened index of suspicion among clinicians caring for affected infants. One in ten infants die from meningitis, and up to half of survivors develop significant lifelong complications, including seizures, impaired hearing and vision, and delayed or arrested development of such basic skills as talking and walking. At present, it is not possible to predict which infants will suffer poor outcomes. Early treatment is critical to promote more favorable outcomes, though diagnosis of meningitis in infants is technically challenging, time-intensive, and invasive. Profound neuronal injury has long been described in the setting of neonatal meningitis, as has elevated levels of many pro- and anti-inflammatory cytokines. Mechanisms of the host immune response that drive clearance of the offending organism and underlie brain injury due to meningitis are not well understood, however. In this review, we will discuss challenges in diagnosis, prognosis, and treatment of neonatal meningitis. We will highlight transcriptomic, proteomic, and metabolomic data that contribute to suggested mechanisms of inflammation and brain injury in this setting with a view toward fruitful areas for future investigation.
Related Concept Videos
01:29Modern Molecular Taxonomy
02:02Genomics